Advertisement

Topics

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

07:00 EST 12 Jan 2015 | BioPortfolio

This article has expired, however you can still download the PDF.
Preview:
About Sickle-cell Anemia Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to....

Other Sources for this Article

Original Article: Sickle-cell Anemia Therapeutics Market in the US 2015-2019

NEXT ARTICLE

More From BioPortfolio on "Sickle-cell Anemia Therapeutics Market in the US 2015-2019"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...